CTLA4 and neoplasm: Furthermore, NETs skew the tumor microenvironment towards an immunosuppressive phenotype [33], e.g., by exhausting CD8+ cytotoxic T cells, the main effector cells of a PD-1/PD-L1 or CTLA4-directed immune checkpoint blockade [27].